Point zero charge of(A) SrO nanoparticles and (B) CS-SrO nanocomposite. door Maria Zaib (22050065)

Onderwerpen:

SEM images of SrO nanoparticles at the scale of (A) 500nm (B) 1µm, and CS-SrO nanocomposite at the scale of (C) 500nm (D) 1µm. door Maria Zaib (22050065)

Onderwerpen:

Isotherm models for adsorption of MO dye on CS-SrO nanocomposite (A) Langmuir model and (B) Freundlich model. door Maria Zaib (22050065)

Onderwerpen:

EDX spectra of green synthesized (A) SrO NPs and (B) CS-SrO. door Maria Zaib (22050065)

Onderwerpen:

pone.0328646.t001 - door Maria Zaib (22050065)

Onderwerpen:

Thermodynamic parameters of dye adsorption (A) MO on CS-SrO nanocomposite (B) CV on SrO nanoparticle. door Maria Zaib (22050065)

Onderwerpen:

Parameters of isotherm models for adsorption of MO and CV on CS-SrO and SrO respectively. door Maria Zaib (22050065)

Onderwerpen:

Thermodynamic parameters for adsorption of MO and CV on CS-SrO nanocomposite and SrO nanoparticles respectively. door Maria Zaib (22050065)

Onderwerpen:

Isotherm models for adsorption of CV dye on SrO nanoparticles (A) Langmuir model, and (B) Freundlich model. door Maria Zaib (22050065)

Onderwerpen:

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings. door Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. door Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. door Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. door Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. door Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... door Diana M. Hendrickx (1507435)